Cetera Advisor Networks LLC Aptinyx Inc. Transaction History

Cetera Advisor Networks LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.12 - $0.69 $16,680 - $95,909	139,000 Added 272.55%	190,000 $22,000
Q4 2022 Feb 14, 2023	BUY	$0.23 - $0.34 $2,530 - $3,740	11,000 Added 27.5%	51,000 $14,000
Q2 2022 Aug 11, 2022	SELL	$0.38 - $2.58 $228 - $1,548	-600 Reduced 1.48%	40,000 $22,000
Q1 2022 May 12, 2022	BUY	$2.27 - $3.62 $92,162 - $146,972	40,600 New	40,600 $92,000
Q2 2021 Aug 13, 2021	SELL	$2.39 - $3.5 $143,400 - $210,000	-60,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.86 - $4.33 $171,600 - $259,800	60,000 New	60,000 $180,000
Q4 2020 Feb 17, 2021	SELL	$2.93 - $4.3 $80,443 - $118,056	-27,455 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.05 - $4.99 $7,487 - $12,250	2,455 Added 9.82%	27,455 $93,000
Q2 2020 Aug 13, 2020	BUY	$1.99 - $4.4 $49,750 - $110,000	25,000 New	25,000 $104,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.